Nano-X Imaging Ltd.(NNOX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
NNOX Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Nano-X Imaging Ltd. (NNOX), a Healthcare sector company. NNOX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (FY 2025), Nano-X Imaging Ltd. reports quarterly revenue of $13.0M, net income of $-75.0M, free cash flow of $-45.0M. Top institutional holders of NNOX by reported 13-F value include BlackRock,, Weiss Asset Management, UBS Group AG, based on the most recent SEC filings. NNOX trades on the Nasdaq exchange and files with the SEC under CIK 1795251. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NNOX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Nano-X Imaging Ltd. directly from SEC EDGAR.
Revenue
FY 2025
$13.0M
Net Income
FY 2025
$-75.0M
Free Cash Flow
FY 2025
$-45.0M
ROIC
FY 2025
-56.0%
D/E Ratio
FY 2025
0.02
AI Insight: NNOX Financial Trends
Nano-X Imaging shows persistent equity decline from $292M in Q4 2021 to $140M in Q4 2025 with no revenue visibility across five years.
• Equity declined from $292M in Q4 2021 to $140M in Q4 2025, a 52% decrease over four years.
• Total debt remained stable at $7M from Q4 2023 through Q4 2025.
⚠ No revenue reported across all periods tracked, indicating pre-commercialization stage with ongoing cash burn.
⚠ Equity burn rate accelerated to $49M in latest year versus $21M in prior year.
AI Insight: NNOX Ratio Trends
Limited financial data available with only debt-to-equity ratios showing gradual increase from 0.01 in Q4 2021 to 0.05 in Q4 2025.
• Debt-to-equity ratio increased from 0.01 in Q4 2021 to 0.05 in Q4 2025, indicating modest leverage expansion.
• All profitability metrics remain unavailable across the five-year period, suggesting ongoing losses or data reporting gaps.
⚠ Absence of operating margin and profitability data prevents assessment of operational efficiency and earnings trajectory.
Get alerted when NNOX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Nano-X Imaging Ltd. including:
Top Institutional Holders of NNOX
BlackRock, Inc.
$8.7M3,818,444 shWeiss Asset Management LP
$6.3M2,793,339 shUBS Group AG
$3.1M1,348,824 shSTATE STREET CORP
$2.8M1,218,948 shGEODE CAPITAL MANAGEMENT, LLC
$2.0M893,098 shARK Investment Management LLC
$1.7M733,290 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$1.4M628,000 shNATIONAL BANK OF CANADA /FI/
$1.3M573,030 shNATIONAL BANK OF CANADA /FI/
$1.3M5,730 shNORTHERN TRUST CORP
$1.2M524,291 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $8.7M | 3,818,444 |
| Weiss Asset Management LP | $6.3M | 2,793,339 |
| UBS Group AG | $3.1M | 1,348,824 |
| STATE STREET CORP | $2.8M | 1,218,948 |
| GEODE CAPITAL MANAGEMENT, LLC | $2.0M | 893,098 |
| ARK Investment Management LLC | $1.7M | 733,290 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.4M | 628,000 |
| NATIONAL BANK OF CANADA /FI/ | $1.3M | 573,030 |
| NATIONAL BANK OF CANADA /FI/ | $1.3M | 5,730 |
| NORTHERN TRUST CORP | $1.2M | 524,291 |
More Healthcare Companies
View all Healthcare →Put NNOX on your watchlist
Track score changes the day Nano-X Imaging Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is NNOX a good stock to buy?
13F Pro's AI-powered analysis of Nano-X Imaging Ltd. (NNOX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NNOX are available on the NNOX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own NNOX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NNOX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Nano-X Imaging Ltd.'s investment landscape.